Scott Verner has been appointed president at Nipro Diagnostics Inc., which was formed last month with the merger of Home Diagnostics Inc. and Nipro Diabetes Systems.


Scott Verner, Nipro Diagnostics, Home Diagnostics Inc., Nipro Diabetes Systems, blood glucose monitoring, insulin pump, merger, diabetes product, Luis Candelario
































































































































































































































INSIDE THIS ISSUE
News
Opinion
Other Services
Reprints / E-Prints
Submit News
White Papers

Supplier News Breaks Archives

Nipro Diagnostics names Verner president

July 1st, 2010

FORT LAUDERDALE, Fla. – Scott Verner has been appointed president at Nipro Diagnostics Inc., which was formed last month with the merger of Home Diagnostics Inc. and Nipro Diabetes Systems.

Nipro said Thursday that with the appointment, which is effective immediately, Verner has responsibility for the company's blood glucose monitoring and insulin pump business in the United States.

Previously, Verner was senior vice president of sales and marketing at Home Diagnostics and then the newly created Nipro Diagnostics. Both of the companies are subsidiaries of Osaka, Japan-based medical device manufacturer Nipro Corp., which unveiled a $215 million deal to acquire Home Diagnostics in early February. The acquisition agreement was finalized in mid-March.

"I am excited to continue making contributions to building Nipro Diagnostics in my new role," Verner said in a statement. "Our product portfolio has further evolved into a comprehensive and competitive offering, meeting a wide range of unique consumer needs and exceptionally high standards for both quality and value. We believe those standards will continue to be the basis of our growth and success over the next several years."

Verner joined Home Diagnostics in 2007 as senior vice president of sales and marketing, in which he was responsible for developing and executing the company's sales and marketing strategy. During his three years in that role, he strengthened the company's sales infrastructure and successfully rebranded and repositioned its blood glucose monitoring product line. That included leveraging new tools to expand Home Diagnostics' market reach, broadening its managed care relationships, and obtaining tier-one or preferred status for the company's products on key managed care formularies.

Before joining Nipro Diagnostics, Verner was vice president of sales at EyeTel Imaging, a company focused on developing technologies to treat diabetes and microvascular disease. Prior to that, he worked for Allergan Inc. where he was instrumental in leading the spin-off of Advanced Medical Optics, and had spent 12 years at Novartis, where he held several sales and marketing positions within the medical device, over-the-counter and pharmaceutical business units.

"We are pleased to appoint Scott Verner as President of Nipro Diagnostics. He is a seasoned health care executive with extensive relationships and deep diabetes industry knowledge," commented Luis Candelario, Nipro Medical Corp. president. "He has already made significant contributions in rebranding and repositioning Nipro Diagnostics' BGM products, driving adoption of that product line and improving our sales infrastructure.

"The combination of Nipro Diagnostics' blood glucose monitoring products with the Amigo Insulin Pump provides a substantial platform to continue building a leading diabetes product company," Candelario added. "Scott is a proven leader and the ideal candidate to leverage this platform and further strengthen our leadership in the diabetes product market."

Nipro Diagnostics offers a portfolio of high-quality blood glucose monitoring products and systems and is the exclusive co-brand supplier of blood glucose monitoring systems for such leading pharmacies as CVS, Rite Aid and Walgreens, as well as distributors such as AmerisourceBergen, Cardinal Health, McKesson, Invacare and Liberty Medical.

Advertisement